… ProQR Announces Presentation on its Axiomer™ RNA Editing Technology at RNA Editing Summit LEIDEN, … ProQR’s website under Presentations & Publications . About Axiomer™ ProQR is pioneering a next-generation RNA base …
… ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting LEIDEN, … it will present new preclinical data for its proprietary Axiomer™ RNA editing technology platform, including the first …
… ProQR to Present Data on its Axiomer® RNA Editing Technology at RNA Editing Summit LEIDEN, … transformative RNA therapies based on its proprietary Axiomer® RNA editing technology platform, today announced a …
… ProQR Announces Japanese Axiomer™ Patent Upheld Following Opposition Against Its … patent directed to its ADAR-mediated RNA editing platform Axiomer™. The opposition was filed in September 2023 with the …
… Announces Preclinical Proof of Concept Data for AX-0810 Axiomer™ RNA Editing Program Targeting NTCP for Cholestatic … leading to meaningful changes in biomarkers in NHPs using Axiomer™ RNA Editing Oligonucleotides Preclinical proof of …
… ProQR to Present Axiomer RNA Editing Platform Technology at RNA Editing Summit … of ProQR will present our proprietary RNA Base Editing Axiomer ® Technology including editing efficiency in various models. “Our Axiomer ® RNA base editing platform uses the body’s own …
… ProQR to Focus Exclusively on Axiomer RNA-editing Technology and Partner Ophthalmology … ProQR to focus exclusively on the development of the Axiomer ® RNA editing technology platform across multiple … growth initiatives related to the advancement of its Axiomer RNA editing platform include both in-house …
… ProQR Announces Conference Call to Discuss the Axiomer® RNA Editing Platform LEIDEN, Netherlands & … conference call and webcast to discuss the Company’s Axiomer RNA editing technology platform following the …
… Research Collaboration on Fibrosis Targets Using ProQR’s Axiomer® technology LEIDEN, the Netherlands, Jan. 08, 2018 … collaboration we will explore a novel application of our Axiomer® technology to Galapagos’ fibrosis targets,” said …